Your browser doesn't support javascript.
loading
Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention.
Contreras Sánchez, Saúl Eduardo; Doubova, Svetlana V; Martinez Vega, Ingrid Patricia; Grajales Álvarez, Rocío; Villalobos Valencia, Ricardo; Dip Borunda, Abdel Karim; Lio Mondragón, Lorena; Martínez Pineda, Wendy Jazmín; Nuñez Cerrillo, Jose Gustavo; Huerta López, Alma Diana; Zalapa Velázquez, Rita; Mendoza Ortiz, Valeria; Vázquez Zamora, Víctor Javier; Montiel Jarquín, Álvaro José; García Galicia, Arturo; Talamantes Gómez, Enrique Isay; Sánchez Reyes, Roberto; Aguirre Gómez, Jaqueline; Ayala Anzures, María Eugenia; Zapata Tarrés, Marta; Monroy, Adriana; Leslie, Hannah H.
Affiliation
  • Contreras Sánchez SE; Epidemiology and Health Services Research Unit CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Doubova SV; Epidemiology and Health Services Research Unit CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico svetlana.doubova@gmail.com.
  • Martinez Vega IP; Epidemiology and Health Services Research Unit CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Grajales Álvarez R; Department of Oncology, Oncology Hospital CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Villalobos Valencia R; Department of Oncology, Oncology Hospital CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Dip Borunda AK; Department of Oncology, Oncology Hospital CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Lio Mondragón L; Department of Radiation Oncology, Oncology Hospital CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Martínez Pineda WJ; Department of Radiation Oncology, Oncology Hospital CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
  • Nuñez Cerrillo JG; Department of Oncology, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • Huerta López AD; Department of Oncology, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • Zalapa Velázquez R; Department of Oncology, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • Mendoza Ortiz V; Department of Oncology, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • Vázquez Zamora VJ; Department of Oncology, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • Montiel Jarquín ÁJ; Department of Education and Research, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • García Galicia A; Department of Education and Research, Speciality Hospital CMN Manuel Ávila Camacho, Mexican Institute of Social Security, Mexico City, Mexico.
  • Talamantes Gómez EI; Department of Oncology, Obstetrics and Gynecology Hospital CMN La Raza, Mexican Institute of Social Security, Mexico City, Mexico.
  • Sánchez Reyes R; Department of Oncology, Obstetrics and Gynecology Hospital CMN La Raza, Mexican Institute of Social Security, Mexico City, Mexico.
  • Aguirre Gómez J; Department of Oncology, Obstetrics and Gynecology Hospital CMN La Raza, Mexican Institute of Social Security, Mexico City, Mexico.
  • Ayala Anzures ME; Department of Oncology, Obstetrics and Gynecology Hospital CMN La Raza, Mexican Institute of Social Security, Mexico City, Mexico.
  • Zapata Tarrés M; Research Coordination, IMSS Foundation, Mexican Institute of Social Security, Mexico City, Mexico.
  • Monroy A; Department of Oncology, Hospital General de México Dr Eduardo Liceaga, Mexico City, Mexico.
  • Leslie HH; Division of Prevention Science, University of California, San Francisco, San Francisco, California, USA.
BMJ Open ; 14(6): e087240, 2024 Jun 21.
Article in En | MEDLINE | ID: mdl-38908841
ABSTRACT

OBJECTIVES:

This study aimed to explore the acceptability, feasibility, usability, and preliminary effect of an electronic patient-reported outcome (ePRO) intervention for patients with breast cancer in Mexico.

DESIGN:

We conducted a multimethod non-randomised pilot study. We used a pre-test/post-test design for quantitative assessment of the intervention's effect on patients' supportive care needs and quality of life. We conducted in-depth interviews (IDIs) with participants and healthcare workers to explore the intervention's benefits and barriers and understand its feasibility.

PARTICIPANTS:

50 women aged 20-75 diagnosed with stage I-III breast cancer were enrolled within 2 weeks of starting neoadjuvant or adjuvant treatment with chemotherapy or radiotherapy. We excluded illiterate women and those with visual impairment, cognitive disability or severe depression. IDIs were conducted with 18 participants and 10 healthcare providers.

SETTING:

Oncology services in three public hospitals of the Mexican Social Security Institute. INTERVENTION The ePRO intervention consisted of a responsive web application for weekly symptom reporting combined with proactive follow-up by nurses guided by predefined clinical algorithms for 6 weeks.

RESULTS:

50 women were enrolled out of 66 eligible patients approached (75.8%). All 50 completed the 4-week follow-up assessment (100% retention). Completion of the symptom registry declined from 100% in week 1 to 66% in week 6. Participants experienced decreases in supportive care needs and increased quality of life. The ePRO application was rated highly usable. Participants and health professionals both perceived intervention benefits. Drawbacks included poor fit for women receiving radiotherapy and challenges using the application for women with low digital literacy or experiencing severe symptoms.

CONCLUSIONS:

This pilot study provided evidence of the high usability and potential efficacy of a web-based ePRO intervention. We revised recruitment during the pilot to include multiple facilities, and we will further revise for the randomised trial to address barriers to successful ePRO implementation. TRIAL REGISTRATION NUMBER ClinicalTrials.gov ID NCT05925257.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Breast Neoplasms / Patient Reported Outcome Measures Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Mexico Language: En Journal: BMJ Open Year: 2024 Document type: Article Affiliation country: Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Breast Neoplasms / Patient Reported Outcome Measures Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Mexico Language: En Journal: BMJ Open Year: 2024 Document type: Article Affiliation country: Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM